Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Esther Bowie MD
Esther M. Bowie MD Advisory Board
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO
Stephanie Watson OAM, BSc, MBBS, FRANZCO, PhD, GAICD, FARVO Advisory Board
Aparna Ramasubramanian MD
Aparna Ramasubramanian MD Advisory Board
See All Experts
featured
Published in Eye Care

Expert Opinion / Commentary · December 16, 2015

2015 Top Stories in Eye Care: Anti-VEGF and Steroid Therapies for Diabetic Macular Edema

Weiye Li MD, PhD

 

 Save  Recommend
 Share

Additional Info

  1. American Society of Retina Specialists Preference and Trends (PAT) Survey 2013 (http://www.asrs.org/asrs-community/ pat-survey).

  2. Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;26; 372(13):1193-1203

  3. Schmit-Eilenberger VK. A novel intravitreal fluocinolone acetonide implant (Iluvien(®)) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series. Clin Ophthalmol. 2015;2015(9):801-811.

Further Reading

Most Read This Week

Recently Updated